Toll-like receptor 2: Therapeutic target for gastric carcinogenesis

Oncotarget

Saved in:

Bibliographic Details
Main Authors:	McCormack, W., Oshima, M., Tan, P., Jenkins, B.J.
Other Authors:	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
Format:	Editorial
Published:	Impact Journals LLC 2014
Subjects:	antineoplastic agent cisplatin epirubicin fluorouracil myeloid differentiation factor 88 opn 301 small interfering RNA toll like receptor 2 unclassified drug advanced cancer antineoplastic activity cancer inhibition cancer recurrence cancer size cancer survival chronic inflammation drug efficacy drug mechanism drug safety editorial gene amplification gene overexpression gene targeting human intracellular signaling nonhuman overall survival somatic mutation stomach cancer stomach carcinogenesis strategic planning survival rate toll like receptor 2 gene upregulation
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/110365
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-110365
record_format	dspace
spelling	sg-nus-scholar.10635-1103652020-11-03T13:29:26Z Toll-like receptor 2: Therapeutic target for gastric carcinogenesis McCormack, W. Oshima, M. Tan, P. Jenkins, B.J. DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE antineoplastic agent cisplatin epirubicin fluorouracil myeloid differentiation factor 88 opn 301 small interfering RNA toll like receptor 2 unclassified drug advanced cancer antineoplastic activity cancer inhibition cancer recurrence cancer size cancer survival chronic inflammation drug efficacy drug mechanism drug safety editorial gene amplification gene overexpression gene targeting human intracellular signaling nonhuman overall survival somatic mutation stomach cancer stomach carcinogenesis strategic planning survival rate toll like receptor 2 gene upregulation Oncotarget 3 11 1260-1261 2014-11-26T08:31:31Z 2014-11-26T08:31:31Z 2012 Editorial McCormack, W., Oshima, M., Tan, P., Jenkins, B.J. (2012). Toll-like receptor 2: Therapeutic target for gastric carcinogenesis. Oncotarget 3 (11) : 1260-1261. ScholarBank@NUS Repository. 19492553 http://scholarbank.nus.edu.sg/handle/10635/110365 NOT_IN_WOS Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Impact Journals LLC Scopus
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	antineoplastic agent cisplatin epirubicin fluorouracil myeloid differentiation factor 88 opn 301 small interfering RNA toll like receptor 2 unclassified drug advanced cancer antineoplastic activity cancer inhibition cancer recurrence cancer size cancer survival chronic inflammation drug efficacy drug mechanism drug safety editorial gene amplification gene overexpression gene targeting human intracellular signaling nonhuman overall survival somatic mutation stomach cancer stomach carcinogenesis strategic planning survival rate toll like receptor 2 gene upregulation
spellingShingle	antineoplastic agent cisplatin epirubicin fluorouracil myeloid differentiation factor 88 opn 301 small interfering RNA toll like receptor 2 unclassified drug advanced cancer antineoplastic activity cancer inhibition cancer recurrence cancer size cancer survival chronic inflammation drug efficacy drug mechanism drug safety editorial gene amplification gene overexpression gene targeting human intracellular signaling nonhuman overall survival somatic mutation stomach cancer stomach carcinogenesis strategic planning survival rate toll like receptor 2 gene upregulation McCormack, W. Oshima, M. Tan, P. Jenkins, B.J. Toll-like receptor 2: Therapeutic target for gastric carcinogenesis
description	Oncotarget
author2	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE
author_facet	DUKE-NUS GRADUATE MEDICAL SCHOOL S'PORE McCormack, W. Oshima, M. Tan, P. Jenkins, B.J.
format	Editorial
author	McCormack, W. Oshima, M. Tan, P. Jenkins, B.J.
author_sort	McCormack, W.
title	Toll-like receptor 2: Therapeutic target for gastric carcinogenesis
title_short	Toll-like receptor 2: Therapeutic target for gastric carcinogenesis
title_full	Toll-like receptor 2: Therapeutic target for gastric carcinogenesis
title_fullStr	Toll-like receptor 2: Therapeutic target for gastric carcinogenesis
title_full_unstemmed	Toll-like receptor 2: Therapeutic target for gastric carcinogenesis
title_sort	toll-like receptor 2: therapeutic target for gastric carcinogenesis
publisher	Impact Journals LLC
publishDate	2014
url	http://scholarbank.nus.edu.sg/handle/10635/110365
_version_	1683423042314698752

Toll-like receptor 2: Therapeutic target for gastric carcinogenesis

Similar Items